News Aprogen Medicines Inc.

Equities

A007460

KR7007460009

End-of-day quote Korea S.E. Other stock markets 23:00:00 19/05/2024 BST			5-day change	1st Jan Change
1,307 ^KRW	-3.47%		-11.81%	+36.15%

03-19	Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Aprogen Medicines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-19	CI
Aprogen Healthcare & Games Inc. announced that it expects to receive KRW 35.00000038 billion in funding from Aprogen Medicines Inc., G-Baise Inc.	12-10	CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
Aprogen Medicines Inc. announced that it has received KRW 5.5 billion in funding	22/10/23	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 5.5 billion in funding	12/10/23	CI
Aprogen Medicines Inc. announced that it has received KRW 70 billion in funding	13/09/23	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 70 billion in funding	07/09/23	CI
Aprogen Medicines Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Aprogen Medicines Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Aprogen Biologics Inc. announced that it has received KRW 40.0000005 billion in funding from Aprogen Medicines Inc.	11/04/23	CI
Aprogen Medicines Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Aprogen Biologics Inc. announced that it expects to receive KRW 50 billion in funding from Aprogen Medicines Inc.	03/10/22	CI
Aprogen Medicines Inc. completed the acquisition of remaining unknown stake in Aprogen, Inc.	17/07/22	CI
Aprogen Medicines Inc. signed a merger contract to acquire remaining unknown stake in Aprogen, Inc.	17/11/21	CI
Aprogen Medicines Inc. announced that it expects to receive KRW 105 billion in funding from Korea Fixed Income Investment Advisory Co., Ltd., Aprogen pharmaceuticals,Inc., Aprogen Healthcare & Games Inc.	15/09/21	CI
Aprogen KIC Inc. announced that it has received KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	20/01/21	CI
Aprogen KIC Inc. cancelled the acquisition of additional 5.6% stake in Aprogen pharmaceuticals,Inc..	13/01/21	CI
Aprogen KIC Inc. announced that it expects to receive KRW 20 billion in funding from Korea Bond Investment Advisory Co., Ltd.	06/01/21	CI
Aprogen KIC Inc. announced that it has received KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	12/10/20	CI
Aprogen KIC Inc. announced that it expects to receive KRW 50 billion in funding from Wooridul Huebrain Ltd. and another investor	11/10/20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Aprogen Medicines Inc.

Equities

A007460

KR7007460009

Summary

Filters